Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Articles by Iatropoulos, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Right arrow Articles by Iatropoulos, M. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity

Gary M. Williams

New York Medical College, Department of Pathology, Basic Science Building, Sunshine Cottage Road, Valhalla, New York 10595, USA

Michael J. Iatropoulos

New York Medical College, Department of Pathology, Basic Science Building, Sunshine Cottage Road, Valhalla, New York 10595, USA

Exposure of experimental animals to biologically effective levels of chemicals, either endogenous or exogenous, the latter of either synthetic or natural origin, elicits a response(s) that reflects the diverse ways in which the various units of organization of an organism deal with chemical perturbation. For some chemicals, an initial response constitutes an adaptive effect that maintains homeostasis. Disruption of this equilibrium at any level of organization leads to an adverse effect, or toxicity. The livers of laboratory animals and humans, like other organs, undergo programmed phases of growth and development, characterized by proliferation followed by differentiation. With organ maturity, the process of differentiation leads to the commitment of differentiated cells to constitutive functions that maintain homeostasis and to specialized functions that serve organismal needs. In the mature livers of all species, proliferation of all cell types subsides to a low level. Thus, the mature liver consists of 2 types of cells: intermediate cells, the hepatocytes, which replicate infrequently, but can respond to signals for replication, and replicating cells, the stem cells, endothelial, Kupffer, and stellate cells (Ito or pericytes), bile duct epithelium, and granular lymphocytes (pit cells). Quantifiable alterations or effects at the molecular level underlie alterations at the organelle level, which in turn lead to alterations at the cellular level, which can ultimately be manifested as a change in the whole organism. Alterations can be quantal (binary), either all or none, as with cell replication, cell necrosis or apoptosis, and cell differentiation, which take place at the cellular level. They can also be graded or continuous (nonbinary), as with enzyme induction, organelle hypertrophy, and extracellular matrix elaboration, occurring either at the intra- or extra (supra) cellular level. Any quantifiable change induced in the function or structure of a cell or tissue constitutes a response or effect. Each of the several types of cell in the liver responds to a given stimulus according to its localization and function. Generally, renewing cells are more vulnerable to chemical injury than intermediate cells, which are largely quiescent. Hepatic adaptive responses usually involve actions of the chemical on cellular regulatory pathways, often receptor mediated, leading to changes in gene expression and ultimately alteration of the metabolome. The response is directed toward maintaining homeostasis through modulation of various cellular and extracellular functions. At all levels of organization, adaptive responses are beneficial in that they enhance the capacity of all units to respond to chemical induced stress, are reversible and preserve viability. Such adaptation at subtoxic exposures is also referred to as hormesis. In contrast, adverse or toxic effects in the liver often involve chemical reaction with cellular macromolecules and produce disruption of homeostasis. Such effects diminish the capacity for response, can be nonreversible at all levels of organization, and can compromise viability. An exposure that elicits an adaptive response can produce toxicity with longer or higher exposures (ie, above a threshold) and the mechanism of action changes with the effective dose. A variety of hepatic adaptive and toxic effects has been identified. Examples of adaptive effects are provided by phenobarbital and ciprofibrate, whereas p-dichlorobenzene and 2-acetylaminofluorene illustrate different toxic effects. The effects of chemicals in the liver are, in general, similar between experimental animals and humans, although exceptions exist. Thus, identification and monitoring of both types of effect are integral in the safety assessment of chemical exposures.

Key Words: Liver cell function • liver cell structure • proliferation • adaptation • toxicity • adverse effects • nonadverse effects.

References

  • Abdo KM, Kari FW ( 1996). The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be modulated by dietary restriction. Exp Toxicol Pathol 48: 129—137.[Web of Science][Medline] [Order article via Infotrieve]
  • Amacher DE, Beck R., Schomaker SJ, Kenny CV (1997). Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat. Toxicol Appl Pharmacol 142: 143—150.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Amacher DE, SchomakerSJ, BurkhardtJE (1998). The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies. Food Chem Toxicol 36: 831—839.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Anugwa FO, Pond WG ( 1989). Growth of whole body and organs of growing rats during feed restriction and subsequent realimentation. Growth Dev Aging 53: 167—174.[Web of Science][Medline] [Order article via Infotrieve]
  • Arias IM, Che M., Gatmaitan Z., Leveille C., Nishida T., St Pierre M. (1993). The biology of the bile canaliculus. Hepatology 17: 318—329.[Web of Science][Medline] [Order article via Infotrieve]
  • Arthur MJ, Bentley IS, Tanner AR, Saunders PK, Millward-Sadler GH, Wright R. (1985). Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 89: 1114—1122.[Web of Science][Medline] [Order article via Infotrieve]
  • Baker GT, III, Shock NW (1991). Theoretical Concepts Governing Gerontological Research. In: The Potential for Nutritional Modulation of Aging Processes, Baker GT, III, Shock NW, Ingram DK (eds). Food and Nutrition Press, Inc, Trumbull, Connecticut, pp 3—22.
  • Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995). Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Blomhoff R., Wake K. ( 1991). Perisinusoidal stellate cells of the liver: Important roles in retinol metabolism and fibrosis. Fed Amer Soc Exp Biol 5: 271—277.
  • Borst P., Evers R., Kool M., Wijnholds J. (1999). The multidrug resistance protein family. Biochim Biophys Acta 1461: 347—357.[Medline] [Order article via Infotrieve]
  • Brauer RW (1963). Liver circulation and function. Physiol Rev 43: 115— 213.[Free Full Text]
  • Breen AP, Murphy JA (1995). Reactions of oxyl radicals with DNA. Free Radic Biol Med 18: 1033—1077.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bresnick E. (1997). Biochemistry of Cancer. In: Cancer Medicine, 1, 4, Holland JF, Bast RC Jr, Morton DL, Frei EI, Kufe DW, Weichselbaum RR (eds). Williams & Wilkins, Baltimore, Maryland, pp 143—164.
  • Brues AM, Drury DR, Brues MC (1936). A quantative study of cell growth in regenerating liver. Arch Pathol 22: 658—673.[Web of Science]
  • Bucher NLR (1963). Regeneration of mammalian liver. Int Rev Cytology 15: 245—300.
  • Budroe JD, Umemura T., Angeloff K., Williams GM (1992). Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofi- brate in C57BL/6N and BALB/c mice. Toxicol Appl Pharmacol 113: 192— 198.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Budunova IV, Williams GM (1994). Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol Toxicol 10: 71—116.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Butterworth BE, Popp JA, Conolly RB, Goldsworthy TL (1992). Chemically induced cell proliferation in carcinogenesis. IARC Sci Publ 279—305.
  • Calabrese EJ, Baldwin LA, Holland CD (1999). Hormesis: A highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Anal 19: 261—281.[Web of Science][Medline] [Order article via Infotrieve]
  • Capen CC (2001). Overview of structural and functional lesions in endocrine organs of animals. Toxicol Pathol 29: 8—33.[Abstract/Free Full Text]
  • Cardell EL, Cardell RR (1997). Structure and Function of Hepatic Parenchymal Cells. In: Comprehensive Toxicology, Vol. 9, Sipes IG, McQueen CA, Gandolfi AJ (eds). Elsevier Science, Inc, New York, pp 11—34.
  • Carthew P., Edwards RE, Nolan BM (1998). The quantitative distinction of hyperplasi a from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Toxicol Sci 44: 46—51.[Abstract/Free Full Text]
  • Casciano DA (2000). Development and utilization of primary hepatocyte culture systems to evaluate metabolism, DNA binding, and DNA repair of xenobiotics. Drug Metab Rev 32: 1—13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen AJ, Grasso P. (1981). Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol 19: 585—605.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SD, Khairallah EA (1997). Selective protein arylation and acetaminophen-induce d hepatotoxicity. Drug Metab Rev 29: 59— 77.[Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SM, Ellwein LB (1990). Cell proliferation in carcinogenesis. Science 249: 1007—1011.[Abstract/Free Full Text]
  • Conney AH (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 42: 4875—4917.[Free Full Text]
  • Conney AH, Davison C., Gastel R., Burns JJ (1960). Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther 130: 1—8.[Abstract/Free Full Text]
  • Conney AH, Miller EC, Miller JA (1956). The metabolism of methylated dyes. 5. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16: 450—455.[Abstract/Free Full Text]
  • Counts JL, Goodman JI (1995). Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: Dose influences mechanism. Regul Toxicol Pharmacol 21: 418—421.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Craddock VM (1971). Liver carcinomas induced in rat by single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst 47: 889—907.[Medline] [Order article via Infotrieve]
  • Crampton RF, Gray TJ, Grasso P., Parke DV (1977). Long-term studies on chemically induced liver enlargement in the rat. I. Sustained induction of microsomal enzymes with absence of liver damage on feeding phenobarbitone or butylated hydroxytoluene. Toxicology 7: 289— 306.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Crampton RF, Gray TJ, Grasso P., Parke DV (1977). Long-term studies on chemically induced liver enlargement in the rat. II. Transient induction of microsomal enzymes leading to liver damage and nodular hyperplasia produced by safrole and Ponceau MX. Toxicology 7: 307—326.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • D'Amours D., Desnoyers S., D'Silva I., Poirier GG (1999). Poly(ADPribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342 (Pt 2): 249—268.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Davies KJ, Quintanilha AT, Brooks GA, Packer L. (1982). Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107: 1198—1205.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Davis JRE (1997). Molecular and cell biology. In: Mechanisms of Disease, Tomlinson S, Heagerty AM, Weetman AP (eds). Cambridge University Press, Cambridge, UK, pp 13—62.
  • Desmet VJ, Van Eyken P, Roskams T. (1999). Embryology of the liver and intrahepatic biliary tract. In: Clinical Hepatology, 1, 2, Bircher J, Benhamou J-P, McIntyre N, Rizzetto M, Rodés J (eds). Oxford University Press, Oxford, UK, pp 51—64.
  • Desmeules J., Bonnabry P., Dayer P. (1999). Hepatic metabolism of drugs. In: Clinical Hepatology, 1, 2, Bircher J, Benhamou J-P, McIntyre N, Rizzetto M, Rodés J (eds). Oxford University Press, Oxford, UK, pp 145— 164.
  • Elia M. (1991). Energy expenditure in the whole body. In: Energy Metabolism, Tissue Determinants and Cellular Corollaries, Kinney MJ, Tucker HN (eds). Raven Press, Ltd, New York, pp 19—59.
  • Elia M. (1991). Organ and tissue contribution to metabolic rate. In: Energy Metabolism, Tissue Determinants and Cellular Corollaries, Kinney JM, Tucker H (eds). Raven Press, Ltd, New York, pp 61—79.
  • Farber E. (1956). Similarities in the sequence of early histologic changes induced in the liver of rats by ethionine, 2-acetylaminofluorene and 3'methyl-4-dimethylaminoazobenzene. Cancer Res 16: 142—148.[Free Full Text]
  • Farber JL (1979). Reactions of the liver to injury: Necrosis. In: Toxic Injury of the Liver, Part A, Farber E, Fisher MM (eds). Marcel Dekker, Inc, New York, pp 215—242.
  • Farber JL (1982). Calcium and the mechanisms of liver necrosis. Prog Liver Dis 7: 347—360.[Web of Science][Medline] [Order article via Infotrieve]
  • Fey GH, Gauldie J. (1990). The acute phase respons e of the liver in inflammation. Prog Liver Dis 9: 89—116.[Medline] [Order article via Infotrieve]
  • Fishback FC (1929). A morphologi c study of regeneration of the liver after partial removal. Arch Pathol 7: 955—977.[Web of Science]
  • Frenkel K. (1992). Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 53: 127—166.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gant TW, O'Connor CK, Corbitt R., Thorgeirsson U., Thorgeirsson SS (1995). In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol Appl Pharmacol 133: 269—276.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gilbert D., Golberg L. (1965). Liver response tests. 3. Liver enlargement and stimulation of microsomal processing enzyme activity. Food Cosmet Toxicol 3: 417—432.[CrossRef][Medline] [Order article via Infotrieve]
  • Greaves P. (1990). Digestive system 2. In: Histopathology of Preclinical Toxicity Studies, Greaves P (ed). Elsevier, New York, pp 393—496.
  • Green DR, Reed JC ( 1998). Mitochondria and apoptosis. Science 281: 1309—1312.[Abstract/Free Full Text]
  • Grisham JW (1962). Morphologic study of deoxyribonucleic acid synthesis and proliferation in regenerating rat liver: autoradiography with thymidine-H 3. Cancer Res 22: 842—849.[Abstract/Free Full Text]
  • Haddad FG, Genecin P., Groszmann RJ (1999). Hepatic blood flow. In: Clinical Hepatology, 1, 2, Bircher J, Benhamou J-P, McIntyre N, Rizzetto M, Rodés J (eds). Oxford University Press, Oxford, UK, pp 65—72.
  • Hart RW, Leakey J., Duffy PH, Feuers RJ, Turturro A. (1996). The effects of dietary restriction on drug testing and toxicity. Exp Toxicol Pathol 48: 121—127.[Web of Science][Medline] [Order article via Infotrieve]
  • Hathway DE (2000). Toxic action/toxicity. Biol Rev Camb Philos Soc 75: 95—127.[Medline] [Order article via Infotrieve]
  • Hipfner DR, Deeley RG, Cole SP ( 1999). Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1461: 359—376.[Medline] [Order article via Infotrieve]
  • Hoffman WE, Wilson BW, Solter PF (1999). Clinical enzymology. In: The Clinical Chemistry of Laboratory Animals, 2nd ed, Loeb WF, Quimby FW (eds). Taylor & Francis, Philadelphia, Pennsylvania, pp 399—454.
  • Iatropoulos M. (1993). Comparative histokinetic and xenodynami c considerations in toxicity. In: Drug Toxicokinetics, Welling PG, de la Inglesia FA (eds). Marcel Dekker, Inc, New York, pp 245—266.
  • Iatropoulos MJ (1994). Endocrine considerations in toxicologic pathology. Exp Toxicol Pathol 45: 391—410.[Web of Science][Medline] [Order article via Infotrieve]
  • Iatropoulos MJ, Williams GM (1996). Proliferation markers. Exp Toxicol Pathol 48: 175—181.[Web of Science][Medline] [Order article via Infotrieve]
  • International Agency for Research on Cancer. (1995). Peroxisome Proliferation and Its Role in Carcinogenesis. Views and Expert Opinions of an IARC Working Group. Lyon, France, IARC, IARC Technical Report No 24.
  • Juliano RL, Ling V. ( 1976). A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152—162.[Medline] [Order article via Infotrieve]
  • Jungermann K. (1995). Zonation of metabolism and gene expression in liver. Histochem Cell Biol 103: 81—91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kacew S., Festing MF (1996). Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J Toxicol Environ Health 47: 1—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Katayama S., Ohmori T., Maeura Y., Croci T., Williams GM (1984). Early stages of N-2-fluorenylacetamide-induce d hepatocarcinogenesi s in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development. J Natl Cancer Inst 73: 141—149.[Web of Science][Medline] [Order article via Infotrieve]
  • Kauffmann HM, Keppler D., Kartenbeck J., Schrenk D. (1997). Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology 26: 980—985.[Web of Science][Medline] [Order article via Infotrieve]
  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coriello GM, Wright WE, Weinrich SL, Shay JW ( 1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011—2015.[Abstract/Free Full Text]
  • Kirkwood TBL (2000). Biological origins of ageing. In: Geriatric Medicine, Evans JG, Williams TF, Beattie BL, Michael J-P, Wilcock GK (eds). Oxford University Press, Oxford, UK, pp 35—51.
  • Klaunig JE, Pereira MA, Ruch RJ, Weghorst CM (1988). Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: Effect of phenobarbital promotion. Toxicol Pathol 16: 381—385.[Web of Science][Medline] [Order article via Infotrieve]
  • Kool M., de Haas M., Scheffer GL, Scheper RJ, van Eijk MJT, Juijn JK, Baas F., Borst P.( 1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537— 3547.[Abstract/Free Full Text]
  • Laskin DL (1991). Parenchymal and nonparenchyma l cell interactions in hepatotoxicity. Adv Exp Med Biol 283: 499—505.[Medline] [Order article via Infotrieve]
  • Lewis W., Dalakas MC (1995). Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417—422.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lindahl T., Wood RD ( 1999). Quality control by DNA repair. Science 286: 1897—1905.[Abstract/Free Full Text]
  • Loewenstein WR (1979). Junctional intercellular communication and the control of growth. Biochim Biophys Acta 560: 1—65.[Medline] [Order article via Infotrieve]
  • MacSween RNM, Scothorne RJ (1994). Developmental anatomy and normal structure. In: Pathology of the Liver, 3, MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC (eds). Churchill Livingstone, New York, pp 1—49.
  • Majno G., Joris I. (1996). Cells Tissues and Disease: Principles of General Pathology. Cambridge, MA, Blackwell Science, pp 16—70, 175—228.
  • Martin DS, Bertino JR, Koutcher JA (2000). ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: Fresh insight for a new approach. Cancer Res 60: 6776—6783.[Free Full Text]
  • Maslansky CJ, Williams GM (1985). Ultraviolet light-induced DNA repair synthesis in hepatocyte s from species of differing longevities. MechAgeing Dev 29: 191—203.
  • Matthews DE, Battezzati A. (1994). Substrate kinetics and catabolic hormones. In: OrganMetabolism and Nutrition, Kinney JM, Tucker HN (eds). Raven Press, New York, pp 1—22.
  • McCuskey RS, Sipes IG (1997). Introduction to the liver and its response to toxicants. In: Comprehensive Toxicology, Vol. 9, Sipes IG, McQueen CA, Gandolfi AJ (eds). Elsevier Science, Inc, New York, pp 1—10.
  • Meyer UA, Hoffmann K. (1999). Phenobarbital-mediated changes in gene expression in the liver. Drug Metab Rev 31: 365—373.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Michalopoulos GK, DeFrances MC (1997). Liver regeneration. Science 276: 60—66.[Abstract/Free Full Text]
  • Moennikes O., Buchmann A., Romualdi A., Ott T., Werringloer J., Wilbecke K., Schwarz M. (2000). Lack of phenobarbital-mediated promotion of hepatocarcinogenesi s in connexin32-nul l mice. Cancer Res 60: 5087—5091.[Abstract/Free Full Text]
  • Nathanson MH, Boyer JL (1991). Mechanisms and regulation of bile secretion. Hepatology 14: 551—566.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • National Toxicology Program (NTP). (1987). Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzen e (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Research Triangle Park, Norh Carolina, NIH Publication No. 87-2575, No. 319: 1—198. NTP Technical Report Series.
  • Nebert DW, Gonzalez FJ (1987). P450 genes: Structure, evolution, and regulation. Annu Rev Biochem 56: 945—993.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nicholson JK, Lindon JC, Holmes E. (1999). `Metabonomics': Understanding the metabolic responses of living systems to pathophysiologica l stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181—1189.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nover L. (1991). Heat Shock Response. CRC Press, Inc, Boca Raton, Florida.
  • O'Connor PJ, Manning FCR, Gordon AT, Billet MA, Cooper DP, Elder RH, Margison GP (2000). DNA repair: kinetics and thresholds. Toxicol Pathol 28: 375—381.[Abstract/Free Full Text]
  • Oda K., Avakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. ( 2000). p53AIP1, a potential mediator of p53-dependen tapoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849—862.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Olsen JH, Schulgen G., Boice JD, Whysner J., Travis LB, Williams GM, Johnson FB, McGee Jo'd (1995). Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 55: 294—297.[Abstract/Free Full Text]
  • Olson H., Betton G., Robinson D., Thomas K., Monro A., Kolaja G., Lilly P., Sanders J., Sipes G., Bracken W., Dorato M., Van Denn K., Smith P., Berger B., Heller A. (2000). Concordance of the toxicity of pharmaceutical s in humans and in animals. Regul Toxicol Pharmacol 32: 56—67.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pandha HS, Sikora K. (1997). Neoplasia. In: Mechanisms of Disease, Tomlinson S, Heagerty AM, Weetman AP (eds). Cambridge University Press, Cambridge, UK, pp 323—362.
  • Paolini M., Mesirca R., Pozzetti L., Sapone A., Cantelli-Forti G. (1995). Induction of CYP2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chem Biol Interact 95: 127—139.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Parkinson A. (1996). Biotransformation of xenobiotics. In: Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th ed, Klaassen CD, Amdur MO (eds). McGraw-Hill, New York, pp 113—186.
  • Patel T., Gores GJ (1995). Apoptosi sand hepatobiliary disease. Hepatology 21: 1725—1741.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pelkonen O. (1994). The role of toxicokinetics in developmental toxicity testing: Lessons from comparative developmental drug metabolism. Drug Infor J 28: 225—234.
  • Peraino C., Fry RJ, Staffeldt E. (1971). Reduction and enhancement by phenobarbital of hepatocarcinogenesi s induced in the rat by 2-acetylaminofluorene. Cancer Res 31: 1506—1512.[Abstract/Free Full Text]
  • Perrone CE, Shao L., Williams GM (1998). Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes. Toxicol Appl Pharmacol 150: 277—286.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pieper AA, Verma A., Zhang J., Snyder SH (1999). Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20: 171— 181.[CrossRef][Medline] [Order article via Infotrieve]
  • Plaa GL, Charbonneau M. (2001). Detection and Evaluation of Chemically Induced Liver Injury. In: Principles and Methods of Toxicology, 4th ed, Hayes AW (ed). Taylor & Francis, Philadelphia, pp 1145—1187.
  • Popp JA, Cattley RC, Miller RT, Marsman DS (1994). Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis. Prog Clin Biol Res 387: 193—207.[Medline] [Order article via Infotrieve]
  • Ratain MJ, Plunkett W. (1997). Pharmacology. In: Cancer Medicine, 4th ed, Holland JF, Bast RC Jr, Morton DL, Frei EI, Kufe DW, Weichselbaum RR (eds). Williams & Wilkins, Baltimore, MD, pp 875—890.
  • Reed JC (1994). Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1—6.[Free Full Text]
  • Remmer H. (1959). Der beschleunigte Abbau von Pharmaka in den Lebermikrosomen unter dem Einfluss von Luminal. Arch Exp Pathol Pharmacol 235:279—290.[Medline] [Order article via Infotrieve]
  • Rice JM, Baan RA, Blettner M., Genevois-Charneau C., Grosse Y., McGregor DB, Partensky C., Wilbourn JD (1999). Rodenttumors of urinary bladder, renal cortex, and thyroid gland in IARC Monographs evaluations of carcinogenic risk to humans. Toxicol Sci 49: 166—171.[Free Full Text]
  • Ringer DP, Norton TR (1987). Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis 8: 1749—1752.[Abstract/Free Full Text]
  • Russell RM (1992). Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 55: 1203S—1207S.[Medline] [Order article via Infotrieve]
  • Santoro MG (2000). Heat shock factors and the control of the stress response. Biochem Pharmacol 59: 55—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Scampini G., Nava A., Newman AJ, Della TP, Mazue G. (1993). Multinucleated hepatocytes induced by rifabutin in rats. Toxicol Pathol 21: 369—376.[Web of Science][Medline] [Order article via Infotrieve]
  • Schulte-Hermann R. (1979). Reactions of the liver to injury: Adaptation. In: Treatise on Liver, Toxic Injury of the Liver, Farber E, Fisher MM (eds). Marcel Dekker, New York, pp 385—444.
  • Searle J., Harmon BV, Bishop CJ, Kerr JFR (1987). The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 2: 77—96.[Web of Science]
  • Sell S. (1990). Is there a liver stem cell? Cancer Res 50: 3811—3815.[Abstract/Free Full Text]
  • Sirma H., Williams GM, Gebhardt R. (1996). Strain- and sex-specific variations in hepatic glutamine synthetase activity and distribution in rats and mice. Liver 16: 166—173.[Web of Science][Medline] [Order article via Infotrieve]
  • Stenback F., Mori H., Furuya K., Williams GM (1986). Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J Natl Cancer Inst 76: 327—333.[Web of Science][Medline] [Order article via Infotrieve]
  • Tanaka T., Mori H., Hirota N., Furuya K., Williams GM (1986). Effect of DNA synthesis on induction of preneoplastic and neoplastic lesions in rat liver by a single dose of methylazoxymethano l acetate. Chem Biol Interact 58: 13—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tanaka T., Mori H., Williams GM (1987). Enhancement of dimethylnitrosamine-initiated hepatocarcinogenesi s in hamsters by subsequent administration of carbon tetrachloride but not phenobarbital or p,p'-dichlorodiphenyltrichloroethane. Carcinogenesis 8: 1171— 1178.[Abstract/Free Full Text]
  • Tong C., Fazio M., Williams GM (1980). Cell cycle-specific mutagenesis at the hypoxanthine phosphoribosyltransferas e locus in adult rat liver epithelial cells. Proc Natl Acad Sci USA 77: 7377—7379.[Abstract/Free Full Text]
  • Trepicchio WL, Bozza M., Bouchard P., Dorner AJ (2001). Protective effect of rhIL-11 in a murine model of acetaminophen-induce d hepatotoxicity. Toxicol Pathol 29: 242—249.[Abstract/Free Full Text]
  • Trosko JE, Chang CC, Madkukar BV (1990). Cell-to-cell communication relationship of stem cells to the carcinogenic process. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, Stevenson DE, McClain RM, Popp JA, Slaga TJ, Ward JM, Pitot HC (eds). Alan R. Liss, New York, pp 259—276.
  • Tugwood, JD, Aldridge, TC, Lambe, KG, McDonald, N., Woodyatt C. (1996). Peroxisome proliferator-activated receptors: Structures and function. New York Acad Sci 804: 252—265.[CrossRef]
  • Umemura T., Kai S., Hasegawa R., Sai K., Kurokawa Y., Williams GM (1999). Pentachlorophenol (PCP) produces liver oxidative stress and promotes but does not initiate hepatocarcinogenesi s in B6C3F1 mice. Carcinogenesis 20: 1115—1120.[Abstract/Free Full Text]
  • Umemura T., Takada K., Schulz C., Gebhardt R., Kurokawa Y., Williams GM (1998). Cell proliferation in the livers of male mice and rats exposed to the carcinogen P-dichlorobenzene: Evidence for thresholds. Drug Chem Toxicol 21: 57—66.[Web of Science][Medline] [Order article via Infotrieve]
  • Umemura T., Tokumo K., Gebhardt R., Poirier M., Williams GM (1993). Dose-response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett 73: 1—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Verna L., Whysner J., Williams GM (1996). 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. Pharmacol Ther 71: 83—105.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wallace DC (1999). Mitochondrial diseases in man and mouse. Science 283: 1482—1488.[Abstract/Free Full Text]
  • Waxman DJ (1999). P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 369: 11—23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Weisiger RA, Fitz JG (1988). Sex differences in membrane potential in the intact perfused rat liver. Am J Physiol 255: G822—G825.[Web of Science][Medline] [Order article via Infotrieve]
  • Whysner J., Ross PM, Williams GM (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71: 153—191.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM (1980). Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Ann NY Acad Sci 349: 273—282.[Medline] [Order article via Infotrieve]
  • Williams GM (1981). Liver carcinogenesis: the role for some chemicals of an epigenetic mechanism of liver-tumour promotion involving modification of the cell membrane. Food Cosmet Toxicol 19: 577—583.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM, Iatropoulos MJ, Jeffrey AM (2000). Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 28: 388—395.[Abstract/Free Full Text]
  • Williams GM, Iatropoulos MJ, Wang CX, Jeffrey AM, Thompson S., Pittman B., Palasch M., Gebhardt R. (1998). Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Toxicol Sci 45: 152—161.[Abstract/Free Full Text]
  • Williams GM, Mori H., McQueen CA (1989). Structure-activity relationships in the rat hepatocyte DNA- repair test for 300 chemicals. Mutat Res 221:263—286.[Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM, Perrone C. (1996). Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens. In: Peroxisomes: Biology and Role in Toxicology and Disease, 804, Reddy JK, Suga T, Mannaerts GP, Lazarow PB, Subramani S (eds). The New York Academy of Sciences, New York, pp 554—572.
  • Wisse E., Braet F., Luo D., Vermijlen D., Edaouks M., Empsen C., Spapen H., Dezanger RBD (1999). Sinusoidal liver cells. In: Clinical Hepatology, 2nd ed, Bircher J, Benhamou J-P, McIntyre N, Rizzetto M, Rodés J (eds). Oxford University Press, Oxford, UK, pp 33—50.
  • Yamamoto K., Fisher MM, Phillips MJ (1985). Hilar biliary plexus in human liver. A comparative study of the intrahepatic bile ducts in man and animals. Lab Invest 52: 103—106.[Web of Science][Medline] [Order article via Infotrieve]
  • Yamasaki H. (1990). Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11: 1051—1058.[Free Full Text]
  • Zhu BT, Lech J., Rosen RT, Conney AH (1997). Effect of dietary 2(3)-tert-butyl-4-hydroxyanisol e on the metabolism and action of estradiol and estrone in female CD-1 mice. Cancer Res 57: 2419—2427.[Abstract/Free Full Text]
  • Williams GM, Jeffrey AM (2000). Oxidative DNA damage: Endogenous and chemically induced. Regul Pharmacol Toxicol 32: 283—292.

Toxicologic Pathology, Vol. 30, No. 1, 41-53 (2002)
DOI: 10.1080/01926230252824699
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
T. Makino, K. Ishikawa, I. Igarashi, T. Yamoto, S. Manabe, and H. Nakayama
Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers
Toxicol Pathol, April 1, 2008; 36(3): 420 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
W. B Jonas and J. A Ives
Should we explore the clinical utility of hormesis?
Human and Experimental Toxicology, February 1, 2008; 27(2): 123 - 127.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Thresholds for the Effects of 2-Acetylaminofluorene in Rat Liver
Toxicol Pathol, February 1, 2004; 32(2_suppl): 85 - 91.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Articles by Iatropoulos, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Right arrow Articles by Iatropoulos, M. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?